LogicBio Therapeutics, Inc. General and Administrative Expense
LogicBio Therapeutics, Inc. reported General and Administrative Expense of $3.41 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2022-11-14
- LogicBio Therapeutics, Inc. general and administrative expense for the quarter ending 2022-09-30 was $3.41M, a 19.90% decline year-over-year.
- LogicBio Therapeutics, Inc. general and administrative expense for the quarter ending 2022-06-30 was $3.26M, a 13.44% decline year-over-year.
- LogicBio Therapeutics, Inc. general and administrative expense for the quarter ending 2022-03-31 was $3.62M, a 10.72% decline year-over-year.
- LogicBio Therapeutics, Inc. general and administrative expense for the quarter ending 2021-12-31 was $4.14M, a 48.51% increase year-over-year.
- LogicBio Therapeutics, Inc. general and administrative expense for fiscal 2021 was $16.23M, a 32.87% increase from fiscal 2020.
- LogicBio Therapeutics, Inc. general and administrative expense for fiscal 2020 was $12.21M, a 17.59% increase from fiscal 2019.
- LogicBio Therapeutics, Inc. general and administrative expense for fiscal 2019 was $10.38M, a 51.30% increase from fiscal 2018.
- LogicBio Therapeutics, Inc. general and administrative expense for fiscal 2018 was $6.86M, a 198.95% increase from fiscal 2017.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $3.41M 10-Q · filed 2022-11-14 | $6.67M derived: sum of 2 quarters · filed 2022-11-14 | $10.29M 10-Q · filed 2022-11-14 | $14.44M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $3.26M 10-Q · filed 2022-08-15 | $6.88M 10-Q · filed 2022-08-15 | $11.03M derived: sum of 3 quarters · filed 2022-08-15 | $15.29M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $3.62M 10-Q · filed 2022-05-16 | $7.77M derived: sum of 2 quarters · filed 2022-05-16 | $12.03M derived: sum of 3 quarters · filed 2022-11-14 | $15.79M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $8.40M derived: sum of 2 quarters · filed 2022-11-14 | $12.17M derived: sum of 3 quarters · filed 2022-11-14 | $16.23M 10-K · filed 2022-03-04 |
| 2021-09-30 | $4.26M 10-Q · filed 2022-11-14 | $8.02M derived: sum of 2 quarters · filed 2022-11-14 | $12.08M 10-Q · filed 2022-11-14 | $14.87M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $3.77M 10-Q · filed 2022-08-15 | $7.82M 10-Q · filed 2022-08-15 | $10.62M derived: sum of 3 quarters · filed 2022-08-15 | $13.81M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $4.06M 10-Q · filed 2022-05-16 | $6.85M derived: sum of 2 quarters · filed 2022-05-16 | $10.05M derived: sum of 3 quarters · filed 2022-05-16 | $13.08M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $5.99M derived: sum of 2 quarters · filed 2022-03-04 | $9.02M derived: sum of 3 quarters · filed 2022-03-04 | $12.21M 10-K · filed 2022-03-04 |
| 2020-09-30 | $3.20M 10-Q · filed 2021-11-15 | $6.23M derived: sum of 2 quarters · filed 2021-11-15 | $9.42M 10-Q · filed 2021-11-15 | $12.47M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $3.03M 10-Q · filed 2021-08-09 | $6.22M 10-Q · filed 2021-08-09 | $9.28M derived: sum of 3 quarters · filed 2021-08-09 | $11.45M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $3.19M 10-Q · filed 2021-05-10 | $6.25M derived: sum of 2 quarters · filed 2021-05-10 | $8.42M derived: sum of 3 quarters · filed 2021-05-10 | $10.95M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $5.23M derived: sum of 2 quarters · filed 2021-03-15 | $7.75M derived: sum of 3 quarters · filed 2021-03-15 | $10.38M 10-K · filed 2021-03-15 |
| 2019-09-30 | $2.17M 10-Q · filed 2020-11-09 | $4.70M derived: sum of 2 quarters · filed 2020-11-09 | $7.33M 10-Q · filed 2020-11-09 | $9.74M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $2.52M 10-Q · filed 2020-08-10 | $5.16M 10-Q · filed 2020-08-10 | $7.57M derived: sum of 3 quarters · filed 2020-08-10 | $9.69M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $2.63M 10-Q · filed 2020-05-11 | $5.04M derived: sum of 2 quarters · filed 2020-05-11 | $7.16M derived: sum of 3 quarters · filed 2020-05-11 | $8.58M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $4.53M derived: sum of 2 quarters · filed 2020-03-16 | $5.95M derived: sum of 3 quarters · filed 2020-03-16 | $6.86M 10-K · filed 2020-03-16 |
| 2018-09-30 | $2.12M 10-Q · filed 2019-11-12 | $3.54M derived: sum of 2 quarters · filed 2019-11-12 | $4.45M 10-Q · filed 2019-11-12 | $5.45M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.42M 10-Q · filed 2019-08-13 | $2.33M 10-Q · filed 2019-08-13 | $3.33M derived: sum of 3 quarters · filed 2019-08-13 | $3.80M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $918.00K 10-Q · filed 2019-05-14 | $1.91M derived: sum of 2 quarters · filed 2019-05-14 | $2.38M derived: sum of 3 quarters · filed 2019-05-14 | |
| 2017-12-31 | $993.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.46M derived: sum of 2 quarters · filed 2019-04-01 | $2.30M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $470.00K 10-Q · filed 2018-12-03 | $1.30M 10-Q · filed 2018-12-03 |